InsidersTradesSigma
GENELUX CORP Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the GENELUX CORP stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €131.8m. The latest transaction was disclosed on 4 August 2026 (Cession). Among the most active insiders: Yu Yong. The full history is openly available.
140
Insider Decl.
n/a
Thresholds
€1,144
10 ops.
Buy Volume
€8m
64 ops.
Sell Volume
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 4 August 2026
Declarations140 total
653 shares@ US$2.9467Common StockSEC:0001493152-26-036076:0
3,023 shares@ US$2.9459Common StockSEC:0001493152-26-036075:0
28,409 sharesCommon StockSEC:0001493152-26-029418:0
174,841 sharesCommon StockSEC:0001493152-26-029419:0
28,409 sharesCommon StockSEC:0001493152-26-029413:0
28,409 sharesCommon StockSEC:0001493152-26-029415:0
28,409 sharesCommon StockSEC:0001493152-26-029416:0
730,601 sharesCommon StockSEC:0001493152-26-029417:0
233,957 sharesCommon StockSEC:0001493152-26-029420:0
278,906 sharesCommon StockSEC:0001493152-26-029421:0
192 shares@ US$2.930.0004% mcap1.6% of flowCommon StockSEC:0001493152-26-027348:0
345 shares@ US$2.422.4% of flowCommon StockSEC:0001493152-26-012972:0
906 shares@ US$2.421.9% of flowCommon StockSEC:0001493152-26-012971:0
3,582 shares@ US$2.423.0% of flowCommon StockSEC:0001493152-26-012969:0
10,000 shares@ US$2.89579.9% of flowCommon StockSEC:0001493152-26-008743:0
12,673 shares@ US$3.326712.7% of flowCommon StockSEC:0001493152-25-027339:0
1,270 shares@ US$3.32673.5% of flowCommon StockSEC:0001493152-25-027337:0
1,244 shares@ US$3.357410.5% of flowCommon StockSEC:0001493152-25-026981:0
10,000 shares@ US$5.000819.3% of flowCommon StockSEC:0001493152-25-025811:0
10,000 shares0Common StockSEC:0001641172-25-026396:0
22,283 shares0Common StockSEC:0001641172-25-026006:0
25 of 140 declarations
About GENELUX CORP
GENELUX CORP is a NASDAQ-listed company focused on developing innovative therapies for cancer treatment. It specializes in the use of oncolytic virus technology to target and destroy cancer cells.